FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Diazepam filed by Hospira, Inc. (ANDA 072079).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Muscle Spasticity
• Seizure Disorders
• Status Epilepticus

Drugs mentioned

• Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)